$2.54 Billion is the total value of Tekla Capital Management LLC's 177 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 5.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Sell | Unitedhealth Group Inc. | $164,110,000 | -2.5% | 319,510 | -3.2% | 6.45% | +9.1% |
| AMGN | Sell | Amgen Inc. | $133,430,000 | -4.0% | 548,418 | -4.6% | 5.24% | +7.4% |
| GILD | Sell | Gilead Sciences, Inc. | $102,034,000 | +1.8% | 1,650,765 | -2.1% | 4.01% | +13.9% |
| VRTX | Buy | Vertex Pharmaceuticals Inc. | $101,791,000 | +26.3% | 361,231 | +16.9% | 4.00% | +41.3% |
| JNJ | Johnson & Johnson | $91,711,000 | +0.2% | 516,652 | 0.0% | 3.60% | +12.1% | |
| ABBV | Buy | AbbVie Inc. | $86,818,000 | -2.3% | 566,842 | +3.4% | 3.41% | +9.3% |
| REGN | Sell | Regeneron Pharmaceuticals, Inc. | $84,451,000 | -17.3% | 142,864 | -2.3% | 3.32% | -7.4% |
| AZN | Buy | AstraZeneca PLCsponsored adr | $74,312,000 | +13.1% | 1,124,741 | +13.5% | 2.92% | +26.5% |
| HZNP | Sell | Horizon Therapeutics plcshares | $69,877,000 | -30.8% | 876,089 | -8.7% | 2.75% | -22.5% |
| ABT | Buy | Abbott Laboratories | $68,155,000 | -6.9% | 627,292 | +1.4% | 2.68% | +4.1% |
| BMY | Buy | Bristol-Myers Squibb Company | $60,271,000 | +14.0% | 782,735 | +8.1% | 2.37% | +27.6% |
| PFE | Sell | Pfizer Inc. | $59,356,000 | -2.2% | 1,132,103 | -3.4% | 2.33% | +9.5% |
| LLY | Sell | Eli Lilly and Company | $57,205,000 | -5.7% | 176,432 | -16.7% | 2.25% | +5.5% |
| TMO | Thermo Fisher Scientific Inc. | $53,027,000 | -8.0% | 97,605 | 0.0% | 2.08% | +2.9% | |
| MCK | Sell | McKesson Corp. | $52,429,000 | -16.9% | 160,722 | -22.0% | 2.06% | -7.0% |
| MRK | Sell | Merck & Co., Inc. | $50,337,000 | +6.6% | 552,122 | -4.1% | 1.98% | +19.2% |
| MRNA | Moderna, Inc. | $46,930,000 | -17.1% | 328,524 | 0.0% | 1.84% | -7.2% | |
| CI | Buy | Cigna Corp. | $45,617,000 | +10.7% | 173,106 | +0.6% | 1.79% | +23.8% |
| SYK | Stryker Corp. | $44,894,000 | -25.6% | 225,678 | 0.0% | 1.76% | -16.8% | |
| ILMN | Sell | Illumina, Inc. | $36,143,000 | -54.3% | 196,047 | -13.3% | 1.42% | -48.8% |
| SGEN | Sell | Seagen Inc. | $34,536,000 | -27.5% | 195,183 | -41.0% | 1.36% | -18.8% |
| DHR | Sell | Danaher Corp. | $31,577,000 | -28.3% | 124,556 | -17.0% | 1.24% | -19.8% |
| HUM | Buy | Humana Inc. | $29,860,000 | +8.0% | 63,794 | +0.4% | 1.17% | +20.8% |
| BSX | Buy | Boston Scientific Corp. | $29,638,000 | +17.5% | 795,215 | +39.7% | 1.16% | +31.5% |
| MOH | Buy | Molina Healthcare, Inc. | $29,383,000 | -6.8% | 105,085 | +11.2% | 1.16% | +4.3% |
| MDT | Sell | Medtronic plcshares | $29,274,000 | -39.4% | 326,172 | -25.0% | 1.15% | -32.2% |
| BIIB | Biogen Inc. | $27,662,000 | -3.2% | 135,639 | 0.0% | 1.09% | +8.4% | |
| JAZZ | Buy | Jazz Pharmaceuticals plcshares | $26,194,000 | +19.8% | 167,899 | +19.5% | 1.03% | +34.0% |
| ZTS | Buy | Zoetis Inc.class a | $25,219,000 | -5.3% | 146,714 | +3.9% | 0.99% | +6.0% |
| SYNH | Sell | Syneos Health, Inc.class a | $21,715,000 | -29.7% | 302,945 | -20.6% | 0.85% | -21.4% |
| ISRG | Buy | Intuitive Surgical, Inc. | $21,311,000 | +22.6% | 106,176 | +84.3% | 0.84% | +37.4% |
| HCA | HCA Healthcare, Inc. | $20,890,000 | -32.9% | 124,303 | 0.0% | 0.82% | -25.0% | |
| ALNY | Sell | Alnylam Pharmaceuticals, Inc. | $18,729,000 | -27.7% | 128,414 | -19.0% | 0.74% | -19.1% |
| IDXX | Sell | IDEXX Laboratories, Inc. | $18,557,000 | -44.6% | 52,910 | -13.6% | 0.73% | -38.0% |
| IQV | Sell | IQVIA Holdings Inc. | $18,293,000 | -19.4% | 84,303 | -14.1% | 0.72% | -9.8% |
| BDX | Becton, Dickinson and Company | $18,226,000 | -7.3% | 73,930 | 0.0% | 0.72% | +3.6% | |
| ICLR | Sell | Icon plcshares | $17,634,000 | -17.8% | 81,375 | -7.8% | 0.69% | -8.1% |
| UTHR | United Therapeutics Corp. | $17,015,000 | +31.3% | 72,206 | 0.0% | 0.67% | +47.0% | |
| WELL | Welltower Inc. | $16,724,000 | -14.3% | 203,083 | 0.0% | 0.66% | -4.2% | |
| NBIX | Buy | Neurocrine Biosciences, Inc. | $16,387,000 | +40.3% | 168,108 | +34.9% | 0.64% | +57.1% |
| EW | Sell | Edwards Lifesciences Corp. | $16,297,000 | -21.9% | 171,388 | -3.3% | 0.64% | -12.7% |
| SRPT | Sell | Sarepta Therapeutics, Inc. | $15,904,000 | -10.6% | 212,165 | -6.8% | 0.62% | 0.0% |
| XBI | Buy | SPDR S&P Biotech ETFs&p biotech etf | $15,534,000 | +80.7% | 209,154 | +118.7% | 0.61% | +102.0% |
| ZBH | Zimmer Biomet Holdings, Inc. | $14,923,000 | -17.9% | 142,044 | 0.0% | 0.59% | -8.2% | |
| RMD | ResMed Inc. | $14,884,000 | -13.6% | 70,999 | 0.0% | 0.58% | -3.3% | |
| Sell | Rallybio Corporation | $14,580,000 | -4.8% | 1,931,120 | -12.0% | 0.57% | +6.5% | |
| ARGX | argenx SEsponsored adr | $14,570,000 | +20.2% | 38,456 | 0.0% | 0.57% | +34.5% | |
| NVO | Sell | Novo Nordisk A/Ssponsored adr | $14,544,000 | -14.7% | 130,523 | -15.0% | 0.57% | -4.5% |
| XLV | Health Care Select Sector SPDR Fundsbi healthcare | $14,521,000 | -6.4% | 113,230 | 0.0% | 0.57% | +4.8% | |
| BNTX | BioNTech SEsponsored ads | $14,171,000 | -12.6% | 95,042 | 0.0% | 0.56% | -2.1% | |
| GH | Guardant Health, Inc. | $14,179,000 | -39.1% | 351,484 | 0.0% | 0.56% | -31.9% | |
| APLS | Buy | Apellis Pharmaceuticals, Inc. | $14,117,000 | +41.9% | 312,192 | +59.4% | 0.56% | +59.0% |
| ITCI | Sell | Intra-Cellular Therapies, Inc. | $13,895,000 | -21.9% | 243,437 | -16.3% | 0.55% | -12.6% |
| VTR | Ventas, Inc. | $12,761,000 | -16.7% | 248,131 | 0.0% | 0.50% | -6.7% | |
| NVS | Novartis AGsponsored adr | $11,515,000 | -3.7% | 136,225 | 0.0% | 0.45% | +7.9% | |
| CVS | Sell | CVS Health Corp. | $11,472,000 | -23.1% | 123,803 | -16.0% | 0.45% | -13.9% |
| BMRN | BioMarin Pharmaceutical Inc. | $10,608,000 | +7.5% | 128,004 | 0.0% | 0.42% | +20.2% | |
| LH | Laboratory Corporation of America Holdings | $10,345,000 | -11.1% | 44,142 | 0.0% | 0.41% | -0.5% | |
| CRL | Sell | Charles River Laboratories International, Inc. | $10,248,000 | -41.8% | 47,894 | -22.7% | 0.40% | -34.8% |
| BHVN | Biohaven Pharmaceutical Holding Company Ltd. | $10,225,000 | +22.9% | 70,176 | 0.0% | 0.40% | +37.7% | |
| KRTX | Sell | Karuna Therapeutics, Inc. | $10,002,000 | -21.5% | 79,057 | -21.3% | 0.39% | -12.1% |
| QURE | uniQure N.V.shares | $9,724,000 | +3.2% | 521,693 | 0.0% | 0.38% | +15.4% | |
| DXCM | Buy | Dexcom, Inc. | $9,680,000 | -48.4% | 129,884 | +254.2% | 0.38% | -42.3% |
| OMI | Owens & Minor, Inc. | $9,063,000 | -28.6% | 288,167 | 0.0% | 0.36% | -20.0% | |
| DOC | Physicians Realty Trust | $8,651,000 | -0.5% | 495,733 | 0.0% | 0.34% | +11.5% | |
| OHI | Omega Healthcare Investors, Inc. | $8,638,000 | -9.5% | 306,433 | 0.0% | 0.34% | +1.2% | |
| LNTH | New | Lantheus Holdings, Inc. | $8,392,000 | – | 127,092 | +100.0% | 0.33% | – |
| BGNE | BeiGene, Ltd.sponsored adr | $8,257,000 | -14.2% | 51,018 | 0.0% | 0.32% | -4.1% | |
| SBRA | Sabra Health Care REIT, Inc. | $7,134,000 | -6.2% | 510,660 | 0.0% | 0.28% | +4.9% | |
| ANTM | Elevance Health, Inc. | $7,067,000 | -1.8% | 14,644 | 0.0% | 0.28% | +9.9% | |
| HQY | Buy | HealthEquity, Inc. | $7,079,000 | +1.6% | 115,314 | +11.6% | 0.28% | +13.5% |
| LTC | LTC Properties, Inc. | $6,998,000 | -0.2% | 182,293 | 0.0% | 0.28% | +11.8% | |
| ADUS | Addus HomeCare Corp. | $6,965,000 | -10.7% | 83,632 | 0.0% | 0.27% | 0.0% | |
| AMN | AMN Healthcare Services, Inc. | $6,714,000 | +5.2% | 61,201 | 0.0% | 0.26% | +17.9% | |
| DNLI | Denali Therapeutics, Inc. | $6,546,000 | -8.5% | 222,420 | 0.0% | 0.26% | +2.4% | |
| IONS | Ionis Pharmaceuticals, Inc. | $6,504,000 | -0.0% | 175,680 | 0.0% | 0.26% | +11.8% | |
| XNCR | Buy | Xencor, Inc. | $6,487,000 | +115.8% | 236,996 | +110.3% | 0.26% | +140.6% |
| ASND | Ascendis Pharma A/Ssponsored adr | $6,302,000 | -20.8% | 67,794 | 0.0% | 0.25% | -11.1% | |
| MPW | Medical Properties Trust, Inc. | $6,287,000 | -27.8% | 411,743 | 0.0% | 0.25% | -19.3% | |
| SNY | Sanofisponsored adr | $6,176,000 | -2.6% | 123,454 | 0.0% | 0.24% | +9.0% | |
| TVTX | Travere Therapeutics, Inc. | $6,001,000 | -6.0% | 247,678 | 0.0% | 0.24% | +5.4% | |
| ALKS | Alkermes plcshares | $5,664,000 | +13.2% | 190,122 | 0.0% | 0.22% | +26.7% | |
| MRTX | Mirati Therapeutics, Inc. | $5,624,000 | -18.4% | 83,784 | 0.0% | 0.22% | -8.7% | |
| BPMC | Buy | Blueprint Medicines Corp. | $5,613,000 | -9.7% | 111,118 | +14.3% | 0.22% | +1.4% |
| ARWR | Buy | Arrowhead Pharmaceuticals, Inc. | $5,524,000 | -10.9% | 156,875 | +16.4% | 0.22% | -0.5% |
| A | Sell | Agilent Technologies, Inc. | $5,130,000 | -42.0% | 43,191 | -35.4% | 0.20% | -35.0% |
| SNN | Smith & Nephew plcsponsored adr | $5,073,000 | -12.5% | 181,710 | 0.0% | 0.20% | -2.5% | |
| ACHC | Acadia Healthcare Company, Inc. | $4,890,000 | +3.2% | 72,307 | 0.0% | 0.19% | +15.7% | |
| CYTK | Cytokinetics, Inc. | $4,711,000 | +6.8% | 119,898 | 0.0% | 0.18% | +19.4% | |
| ALGN | Align Technology, Inc. | $4,472,000 | -45.7% | 18,894 | 0.0% | 0.18% | -39.1% | |
| New | R1 RCM Inc. | $4,241,000 | – | 202,351 | +100.0% | 0.17% | – | |
| VECT | VectivBio Holding AGordinary shares | $4,085,000 | +14.9% | 756,502 | 0.0% | 0.16% | +28.8% | |
| PEAK | Healthpeak Properties, Inc. | $3,897,000 | -24.5% | 150,392 | 0.0% | 0.15% | -15.5% | |
| Caribou Biosciences, Inc. | $3,798,000 | -40.8% | 699,377 | 0.0% | 0.15% | -33.8% | ||
| ARVN | Arvinas, Inc. | $3,620,000 | -37.5% | 85,997 | 0.0% | 0.14% | -30.0% | |
| PHG | Koninklijke Philips N.V.ny reg shares | $3,548,000 | -29.5% | 164,790 | 0.0% | 0.14% | -21.5% | |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $3,457,000 | -19.9% | 459,651 | 0.0% | 0.14% | -10.5% | |
| STE | STERIS plcshares | $3,436,000 | -14.7% | 16,669 | 0.0% | 0.14% | -4.9% | |
| CRSP | CRISPR Therapeutics AGnamen akt | $3,347,000 | -3.2% | 55,080 | 0.0% | 0.13% | +9.1% | |
| NVAX | Novavax, Inc. | $3,281,000 | -30.2% | 63,800 | 0.0% | 0.13% | -21.8% | |
| ARQT | Buy | Arcutis Biotherapeutics, Inc. | $3,173,000 | +25.2% | 148,874 | +13.1% | 0.12% | +40.4% |
| VRNA | Verona Pharma plcsponsored adr | $3,150,000 | -16.0% | 751,905 | 0.0% | 0.12% | -6.1% | |
| NTLA | Intellia Therapeutics, Inc. | $3,011,000 | -28.8% | 58,180 | 0.0% | 0.12% | -20.3% | |
| BCRX | Buy | BioCryst Pharmaceuticals, Inc. | $2,935,000 | -8.2% | 277,434 | +41.1% | 0.12% | +2.7% |
| HR | Healthcare Realty Trust Inc. | $2,829,000 | -1.0% | 104,024 | 0.0% | 0.11% | +11.0% | |
| ADPT | Adaptive Biotechnologies Corp. | $2,732,000 | -41.7% | 337,722 | 0.0% | 0.11% | -35.2% | |
| RARE | Sell | Ultragenyx Pharmaceutical Inc. | $2,647,000 | -74.1% | 44,365 | -68.5% | 0.10% | -71.0% |
| CERE | Buy | Cerevel Therapeutics Holdings, Inc. | $2,331,000 | -9.7% | 88,173 | +19.7% | 0.09% | +1.1% |
| MRUS | Merus N.V. | $2,157,000 | -14.4% | 95,290 | 0.0% | 0.08% | -3.4% | |
| PRGO | Perrigo Company plcshares | $2,078,000 | +5.5% | 51,224 | 0.0% | 0.08% | +18.8% | |
| GTHX | G1 Therapeutics, Inc. | $2,094,000 | -35.0% | 423,869 | 0.0% | 0.08% | -27.4% | |
| HTA | Healthcare Trust of America, Inc. | $1,972,000 | -11.0% | 70,662 | 0.0% | 0.08% | -1.3% | |
| GMRE | Global Medical REIT Inc. | $1,964,000 | -31.2% | 174,897 | 0.0% | 0.08% | -23.0% | |
| HOLX | Hologic, Inc. | $1,964,000 | -9.8% | 28,347 | 0.0% | 0.08% | +1.3% | |
| CCXI | ChemoCentryx, Inc. | $1,938,000 | -1.1% | 78,197 | 0.0% | 0.08% | +10.1% | |
| IMAB | I-Mabsponsored ads | $1,837,000 | -30.4% | 162,580 | 0.0% | 0.07% | -22.6% | |
| MREO | Mereo BioPharma Group plcads | $1,737,000 | 0.0% | 1,551,082 | 0.0% | 0.07% | +11.5% | |
| Pyxis Oncology, Inc. | $1,686,000 | -35.9% | 708,303 | 0.0% | 0.07% | -28.3% | ||
| AUPH | Aurinia Pharmaceuticals Inc. | $1,634,000 | -18.8% | 162,599 | 0.0% | 0.06% | -9.9% | |
| AFMD | Affimed N.V. | $1,623,000 | -36.6% | 586,038 | 0.0% | 0.06% | -28.9% | |
| DSGN | Buy | Design Therapeutics, Inc. | $1,518,000 | +43.9% | 108,414 | +65.9% | 0.06% | +62.2% |
| ZLAB | Zai Lab Ltd.adr | $1,502,000 | -21.1% | 43,300 | 0.0% | 0.06% | -11.9% | |
| TAK | Sell | Takeda Pharmaceutical Company Ltd.sponsored ads | $1,475,000 | -51.0% | 105,073 | -50.0% | 0.06% | -45.3% |
| RXDX | Buy | Prometheus Biosciences, Inc. | $1,389,000 | +66.3% | 49,195 | +122.5% | 0.06% | +89.7% |
| MEDP | Medpace Holdings, Inc. | $1,412,000 | -8.5% | 9,435 | 0.0% | 0.06% | +1.9% | |
| COGT | New | Cogent Biosciences, Inc. | $1,325,000 | – | 146,911 | +100.0% | 0.05% | – |
| RNA | Buy | Avidity Biosciences, Inc. | $1,238,000 | +153.2% | 85,218 | +222.2% | 0.05% | +188.2% |
| ASRT | Assertio Holdings, Inc. | $1,211,000 | +2.8% | 410,575 | 0.0% | 0.05% | +17.1% | |
| WAT | Sell | Waters Corp. | $1,192,000 | -86.5% | 3,600 | -87.4% | 0.05% | -84.8% |
| GRTX | Galera Therapeutics, Inc. | $1,168,000 | -45.4% | 898,374 | 0.0% | 0.05% | -38.7% | |
| Stevanato Group Societa' Per Azioniordinary shares | $1,126,000 | -21.4% | 71,190 | 0.0% | 0.04% | -12.0% | ||
| SNDX | Syndax Pharmaceuticals, Inc. | $1,087,000 | +10.7% | 56,480 | 0.0% | 0.04% | +26.5% | |
| ACAD | ACADIA Pharmaceuticals Inc. | $1,018,000 | -41.8% | 72,225 | 0.0% | 0.04% | -34.4% | |
| PTGX | Protagonist Therapeutics, Inc. | $967,000 | -66.6% | 122,271 | 0.0% | 0.04% | -62.7% | |
| MORF | Buy | Morphic Holding, Inc. | $968,000 | -31.2% | 44,625 | +27.4% | 0.04% | -22.4% |
| ACET | Adicet Bio, Inc. | $925,000 | -26.9% | 63,329 | 0.0% | 0.04% | -18.2% | |
| XENE | New | Xenon Pharmaceuticals Inc. | $904,000 | – | 29,710 | +100.0% | 0.04% | – |
| STRO | Sutro Biopharma, Inc. | $854,000 | -36.6% | 163,924 | 0.0% | 0.03% | -27.7% | |
| FATE | Fate Therapeutics, Inc. | $784,000 | -36.1% | 31,652 | 0.0% | 0.03% | -27.9% | |
| NTRA | New | Natera, Inc. | $758,000 | – | 21,400 | +100.0% | 0.03% | – |
| ICPT | Intercept Pharmaceuticals, Inc. | $719,000 | -15.1% | 52,067 | 0.0% | 0.03% | -6.7% | |
| DHC | Diversified Healthcare Trust | $651,000 | -43.1% | 357,720 | 0.0% | 0.03% | -35.0% | |
| TScan Therapeutics, Inc. | $629,000 | +12.3% | 200,000 | 0.0% | 0.02% | +25.0% | ||
| NHI | National Health Investors, Inc. | $608,000 | +2.7% | 10,038 | 0.0% | 0.02% | +14.3% | |
| BEAM | Beam Therapeutics Inc. | $612,000 | -32.5% | 15,817 | 0.0% | 0.02% | -25.0% | |
| UHT | Universal Health Realty Income Trustshares | $599,000 | -8.8% | 11,258 | 0.0% | 0.02% | +4.3% | |
| SRRK | Scholar Rock Holding Corp. | $597,000 | -57.4% | 108,833 | 0.0% | 0.02% | -53.1% | |
| Theseus Pharmaceuticals, Inc. | $553,000 | -52.0% | 100,000 | 0.0% | 0.02% | -45.0% | ||
| CHCT | Community Healthcare Trust Inc. | $540,000 | -14.1% | 14,900 | 0.0% | 0.02% | -4.5% | |
| ALXO | ALX Oncology Holdings Inc. | $536,000 | -52.1% | 66,211 | 0.0% | 0.02% | -46.2% | |
| HARP | Harpoon Therapeutics, Inc. | $496,000 | -61.6% | 259,910 | 0.0% | 0.02% | -57.8% | |
| EWTX | Edgewise Therapeutics, Inc. | $482,000 | -17.9% | 60,550 | 0.0% | 0.02% | -9.5% | |
| QGEN | Sell | Qiagen N.V.shares | $496,000 | -90.6% | 10,500 | -90.3% | 0.02% | -89.8% |
| ITOS | Sell | iTeos Therapeutics, Inc. | $436,000 | -68.0% | 21,181 | -50.0% | 0.02% | -64.6% |
| RPTX | Repare Therapeutics Inc. | $408,000 | -1.7% | 29,150 | 0.0% | 0.02% | +6.7% | |
| MOR | MorphoSys AGsponsored ads | $396,000 | -28.6% | 81,867 | 0.0% | 0.02% | -15.8% | |
| UHS | Universal Health Services, Inc.class b | $403,000 | -30.5% | 4,000 | 0.0% | 0.02% | -20.0% | |
| New | Embecta Corp. | $374,000 | – | 14,786 | +100.0% | 0.02% | – | |
| NKTX | Nkarta, Inc. | $357,000 | +8.2% | 28,988 | 0.0% | 0.01% | +16.7% | |
| DTIL | Precision BioSciences, Inc. | $359,000 | -48.1% | 224,534 | 0.0% | 0.01% | -41.7% | |
| BCYC | Buy | Bicycle Therapeutics PLCsponsored ads | $337,000 | -23.9% | 20,065 | +98.9% | 0.01% | -18.8% |
| BDTX | Black Diamond Therapeutics, Inc. | $325,000 | -11.2% | 131,990 | 0.0% | 0.01% | 0.0% | |
| CYH | Community Health Systems, Inc. | $331,000 | -68.4% | 88,335 | 0.0% | 0.01% | -64.9% | |
| ARDX | Ardelyx, Inc. | $318,000 | -44.9% | 539,408 | 0.0% | 0.01% | -40.0% | |
| FULC | Sell | Fulcrum Therapeutics, Inc. | $287,000 | -84.3% | 58,537 | -24.3% | 0.01% | -82.8% |
| ONEM | 1Life Healthcare, Inc. | $245,000 | -29.2% | 31,266 | 0.0% | 0.01% | -16.7% | |
| ENDP | Endo International plcshares | $230,000 | -79.9% | 494,607 | 0.0% | 0.01% | -77.5% | |
| ZimVie Inc. | $227,000 | -29.9% | 14,202 | 0.0% | 0.01% | -18.2% | ||
| PRAX | Praxis Precision Medicines, Inc. | $184,000 | -76.0% | 75,000 | 0.0% | 0.01% | -74.1% | |
| FUSN | Fusion Pharmaceuticals Inc. | $108,000 | -68.0% | 43,394 | 0.0% | 0.00% | -66.7% | |
| SPPI | Spectrum Pharmaceuticals, Inc. | $89,000 | -39.9% | 114,670 | 0.0% | 0.00% | -40.0% | |
| ABIO | ARCA biopharma, Inc. | $81,000 | +8.0% | 32,461 | 0.0% | 0.00% | 0.0% | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $39,000 | -52.4% | 154,310 | 0.0% | 0.00% | -33.3% | |
| VYNE | VYNE Therapeutics Inc. | $53,000 | -39.8% | 135,395 | 0.0% | 0.00% | -33.3% | |
| FVE | AlerisLife Inc. | $29,000 | -44.2% | 24,237 | 0.0% | 0.00% | -50.0% | |
| NexGel, Inc. | $7,000 | -12.5% | 4,243 | 0.0% | 0.00% | – | ||
| Bellicum Pharmaceuticals, Inc. | $7,000 | -46.2% | 6,000 | 0.0% | 0.00% | – | ||
| HLXA | Exit | Helix Acquisition Corp.class a | $0 | – | -250,000 | -100.0% | -0.10% | – |
| XRAY | Exit | DENTSPLY SIRONA Inc. | $0 | – | -57,400 | -100.0% | -0.10% | – |
| RCM | Exit | R1 RCM Inc. | $0 | – | -202,351 | -100.0% | -0.19% | – |
| PKI | Exit | PerkinElmer, Inc. | $0 | – | -33,444 | -100.0% | -0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-07-29
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.